{
    "title": "Baxter to divest biopharma business for $4.25 billion",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12059709/Warburg-Advent-buy-Baxters-biopharma-business-4-25-billion.html",
    "date": "2023-05-08",
    "keywords": [
        "baxter",
        "privateequity",
        "device",
        "pincus",
        "unit",
        "business",
        "debt",
        "development",
        "deal",
        "drug",
        "inc",
        "monday",
        "group",
        "warburg",
        "supplychain",
        "labor",
        "transportation",
        "intent",
        "kidney",
        "care",
        "restructuring",
        "alignment",
        "companys",
        "manufacturing",
        "footprint",
        "consortium",
        "lead",
        "company",
        "maker",
        "hillrom",
        "market",
        "value",
        "dec",
        "transaction",
        "share",
        "quarter",
        "formulation",
        "commercialization",
        "infusion",
        "injection",
        "access",
        "bloomington",
        "indiana",
        "sector",
        "uncertainty",
        "half",
        "presence",
        "contract",
        "space",
        "reporting",
        "khushi",
        "mandowara",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}